The most advanced of them, danuglipron, has demonstrated good efficacy in a twice-daily formulation, and we believe a once-daily formulation has the potential to have a competitive profile in the oral GLP-1 space, said Mikael Dolsten, MD., PhD., chief scientific officer & president, Pfizer Research and Development
Ingredient-Specific Considerations Glutathione: Oral forms are generally well tolerated at standard doses
elevated triglycerides (defined as 150 mg/dL), decreased High Density Lipoprotein (HDL) (ranges below 40 mg/dL in men and 50 mg/dL in women), elevated blood pressure (defined as systolic blood pressure above 130 mmHg or diastolic blood pressure above 85 mmHg) and elevated fasting glucose (defined as blood glucose above 100 mg/dL)
If you have trouble swallowing tablets, see this article for tips on taking this form of medication
It also provides clear instructions for use and precautions to ensure safe consumption